Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
about
Optimizing sedation in patients with acute brain injuryCurrent practices of mobilization, analgesia, relaxants and sedation in Indian ICUs: A survey conducted by the Indian Society of Critical Care MedicinePharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions.Population Pharmacokinetics of Fentanyl in the Critically IllPharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsionsPharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill PatientsPopulation pharmacokinetics of ceftazidime in intensive care unit patients: influence of glomerular filtration rate, mechanical ventilation, and reason for admission.Pain management in neurocritical care.Approaches for dosage individualisation in critically ill patients.The Future of Intensive Care Unit Sedation: A Report of Continuous Infusion Ketamine as an Alternative Sedative Agent.Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus.A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications.Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.Sedative Plasma Concentrations and Delirium Risk in Critical Illness.Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure.CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients.Pharmacokinetics of midazolam in resuscitated patients treated with moderate hypothermia.Population Pharmacokinetic/ Pharmacodynamic Modelling of Auditory-Evoked Event-Related Potentials with Lorazepam.Psychotropic drug therapy in patients in the intensive care unit - usage, adverse effects, and drug interactions: a review
P2860
Q26752789-DB7158F1-73A4-43BF-9578-9E47BD729344Q34201602-1B7DEDD2-54E1-44D4-BA2E-FE00CF3C6A1AQ36536031-E4FFA2E9-77BB-4A65-9C1D-94C577593670Q36586522-A6DE575F-5235-4437-BC51-B9A67B884293Q36922248-A3C88379-82DB-4950-B74B-C74E613C46DCQ37268459-83D453AF-5CC8-471C-9DBB-0C63C9FB7E6BQ37392874-5713B35F-DC93-4735-AEF7-F54071C4BD0AQ38124745-B065A6FF-A7DE-4202-90EF-0DFFF63D2337Q38125209-ED36B469-4865-45A8-B4B3-4439F1A2EE20Q38872319-0A5A22D1-6B82-41B5-8C75-36796F12E7DCQ38972539-9596E484-0509-4D75-AEC6-33E978D5D8BBQ39109020-07EC011F-8F40-4A92-8511-5C9A9C6F5794Q39175922-5AE435FB-4A46-418E-A733-CC61C092247CQ39767125-7B2253CD-E4F6-46FF-AD7F-8AD61250A3DEQ47552518-076153DE-AEEA-4AB4-9402-D849B6069A0AQ47600971-6F0F4FD1-0A14-4D95-9B08-785B63368714Q47951996-657CB604-2201-481F-8288-5B68F7A492D3Q48111784-29232622-0B4C-4B5D-9DE8-08BCFD341780Q48127960-BF14C670-7CA2-4340-8FB5-01C06EB5333EQ57490627-18CAD872-C79A-418B-9F40-2E289462C9D4
P2860
Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Comparative population pharmac ...... on in critically ill patients.
@ast
Comparative population pharmac ...... on in critically ill patients.
@en
type
label
Comparative population pharmac ...... on in critically ill patients.
@ast
Comparative population pharmac ...... on in critically ill patients.
@en
prefLabel
Comparative population pharmac ...... on in critically ill patients.
@ast
Comparative population pharmac ...... on in critically ill patients.
@en
P2093
P2860
P1476
Comparative population pharmac ...... ion in critically ill patients
@en
P2093
Eleonora L Swart
Klaas P Zuideveld
Lambertus G Thijs
Meindert Danhof
Robert M J Strack van Schijndel
P2860
P304
P356
10.1046/J.1365-2125.2003.01957.X
P407
P577
2004-02-01T00:00:00Z